n/a (DXR)

: DXR · Real-Time Price · USD

n/a

n/a (n/a)

At close: Invalid Date

No data available

Bid	n/a
Market Cap	n/a
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Beta	n/a
EPS (ttm)	n/a
PE Ratio (ttm)	n/a
Forward PE	n/a
P/B (ttm)	n/a
P/S (ttm)	n/a
Earnings Date	May 13, 2004

Ask	n/a
Volume	NaN
Avg. Volume (20D)	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a - n/a
52-Week Range	n/a - n/a
Analyst	n/a
Price Target	n/a
Dividends	n/a
Ex-Dividend Date	n/a

About DXR

A detailed description of the company is not yet available....

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees n/a

Stock Exchange n/a

Ticker Symbol DXR

Full Company Profile

Earnings Surprise

has released their quarterly earnings on Aug 26, 2019:

Revenue of n/a misses estimates by $0, with NaN% YoY growth.

EPS of 0.06 exceeds estimates by 0.04, with -79.31% YoY decline.

Next Earnings Release

is scheduled to release its earnings on May 13, 2004, before market opens.
Analysts project revenue of ... Upgrade

News

5 months ago · MarketBeat

Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha

Daxor (NASDAQ:DXR) used its presentation at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 to outline its focus on blood volume analysis and the company’s commercialization pla...